At a glance
ClinicalIndex Comparison RecordN/ACompleted· 89 enrolled
Drug / intervention
computed tomography +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study of Positron Emission Tomography/CT Scan for Response Evaluation After Radiofrequency Ablation in Patients With Lung Metastases
In Brief
A clinical study evaluating computed tomography, positron emission tomography, and 1 other intervention for Metastatic Cancer and Unspecified Adult Solid Tumor, Protocol Specific. Completed, enrolled 89 participants across 3 sites.
Detailed Summary
RATIONALE: Radiofrequency ablation uses a high-frequency, electric current to kill tumor cells. Diagnostic procedures, such as PET scan and CT scan, may help doctors measure the patient's response to treatment. PURPOSE: This clinical trial is studying PET scan and CT scan to see how well they work in evaluating response to treatment in patients undergoing radiofrequency ablation for lung metastases.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesFrance
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2005
First PostedSep 2006
Primary CompletionDec 2009
Study CompletionMay 2011
TodayJul 2026
First PostedSep 28, 2006
Enrollment StartMay 2, 2005
Primary CompletionDec 1, 2009
Study CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 19.8 years ago
Interventions
computed tomographyprocedure
positron emission tomographyprocedure
radiofrequency ablationprocedure